Condition: Atrial Fibrillation · Sponsor: Biosense Webster, Inc.
The purpose of this study is to evaluate the long-term safety and effectiveness of the FDA approved VARIPULSE catheter system for pulmonary vein isolation (PVI) in the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF).
This description comes directly from the study's public registry record.
Emily Purcell · +1 949 230 3701 · EPurcel1@its.jnj.com
Always discuss trial participation with your own doctor first.
| Phoenix Cardiovascular Research Group | Phoenix, Arizona, United States | Recruiting |
| Tucson Medical Center Pima Heart and Vascular | Tucson, Arizona, United States | Recruiting |
| OC Memorial | Fountain Valley, California, United States | Recruiting |
| San Diego Cardiac Center | San Diego, California, United States | Withdrawn |
| Stanford Hospital and Clinics | Stanford, California, United States | Withdrawn |
| Community Memorial Hospital | Ventura, California, United States | Recruiting |
| Aurora Denver Cardiology Associates | Aurora, Colorado, United States | Recruiting |
| Colorado Heart and Vascular PC | Golden, Colorado, United States | Withdrawn |
| HCA Florida Mercy Hospital | Miami, Florida, United States | Recruiting |
| Orlando Health Heart and Vascular Institute | Orlando, Florida, United States | Recruiting |
| Deaconess Gateway Hospital | Newburgh, Indiana, United States | Withdrawn |
| The Kansas City Heart Rhythm Institute | Overland Park, Kansas, United States | Recruiting |
+ 11 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.